|
|||||
|
|
Correlation of estrogen receptor beta gene polymorphisms with spinal bone mineral density in peri- and post-menopausal Greek women |
|
| Authors: | Efstathiadou Z Koukoulis G Stakias N Challa A Zintzaras E Tsatsoulis A |
| Affiliation: | aDivision of Endocrinology, Department of Internal Medicine, University of Ioannina School of Medicine, 45110 Ioannina, Greece bDepartment of Endocrinology, Sector of Internal Medicine, University of Thessaly School of Medicine, Larissa, Greece cLaboratory of Child Health, Department of Paediatrics, University of Ioannina School of Medicine, Ioannina, Greece dLaboratory of Biomathematics, University of Thessaly School of Medicine, Larissa, Greece |
| Abstract: | Estrogens play a significant role in bone physiology. Their action is mainly exerted through their receptors. Estrogen receptor alpha (ER) plays a major role in bone homeostasis and there is evidence suggesting that estrogen receptor beta (ERβ) has also an effect on BMD. We investigated the possible effect of two ERβ gene polymorphisms on spinal bone mineral density (BMD) and metabolic bone markers in Greek women. Spine BMD as well as biochemical bone markers were measured in 147 healthy peri- and post-menopausal women [mean age (S.D.) 54 (7.9) years]. Genotyping was performed for two restriction fragment length polymorphisms (RFLPs) of ERβ gene, RsaI in exon 5 and AluI in exon 8. For each polymorphism studied the cohort was divided into two groups: the “wild-type” group (RR and AA, respectively) and the “carrier” group including subjects with at least one allele with the restriction site (Rr&rr and Aa&aa, respectively). The distribution of RsaI genotypes was RR: 91.2% (n = 134), Rr: 8.2% (n = 12), and rr: 0.6% (n = 1) and of AluI genotypes AA: 36.7% (n = 54), Aa: 57.2% (n = 84), and aa: 6.1% (n = 9). No linkage disequilibrium was found between the two polymorphic sites studied. Spine BMD did not differ significantly in the two groups of either polymorphism, after adjusting for age, weight, height, and years since menopause [mean BMD (S.D.) for RR 0.841 (0.17) g/cm2 versus Rr&rr 0.798 (0.13) g/cm2, p = 0.25, and mean BMD (S.D.) for AA 0.828 (0.16) g/cm2 versus Aa&aa 0.848 (0.17) g/cm2, p = 0.32]. No significant differences were noted in metabolic bone markers except for a marginal difference of RR versus Rr/rr in urinary hydroxyproline/creatinine ratio [median (IQR) 3.88 (6.04) μmol/mmol in RR versus 8.2 (4.32) μmol/mmol in Rr/rr, p = 0.05]. Furthermore, no interaction between the two polymorphisms on BMD was found. In conclusion, in a Greek female post-menopausal population, the two ERβ gene polymorphisms were not associated with BMD, or metabolic bone markers. |
| Keywords: | Bone mineral density Estrogen receptor Osteoporosis ERβ polymorphism |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |